Interferon-beta inhibits mitogen induced astrocyte proliferation in vitro

被引:29
|
作者
Malik, O
Compston, DAS
Scolding, NJ
机构
[1] Addenbrookes Hosp, Dept Neurol, Cambridge CB2 2QQ, England
[2] Univ Cambridge, MRC, Ctr Brain Repair, Cambridge CB2 2PY, England
基金
英国医学研究理事会;
关键词
multiple sclerosis; reactive astrocyte; growth factors; cytokines;
D O I
10.1016/S0165-5728(98)00049-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The central nervous system response to injury and inflammation commonly includes astrocytosis. This process, which is manifest by astrocyte hypertrophy and proliferation, is particularly prominent in multiple sclerosis (MS), where in chronic lesions it may contribute to the lack of repair by restricting the migration of remyelinating cells. Interferon-beta (IFN-beta) modestly reduces the frequency of relapses in MS and may have a small effect on the accumulation of permanent disability. Here, we show that IFN-P inhibits the in vitro proliferative response of rodent astrocytes to a wide variety of growth factors and cytokines. Although important species differences exist in these glial responses this previously unrecognised property of IFN-P may have implications for reducing astrocytosis and thereby promoting endogenous repair. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 50 条
  • [1] Cyclosporin A Inhibits Rotavirus Replication and Restores Interferon-Beta Signaling Pathway In Vitro and In Vivo
    Shen, Zigang
    He, Haiyang
    Wu, Yuzhang
    Li, Jintao
    PLOS ONE, 2013, 8 (08):
  • [2] Interferon-beta exhibits an effect on myelination in vitro
    Jangouk, Parastoo
    Bernal, Fabian
    Koehne, Angelika
    Dehmel, Thomas
    Hartung, Hans-Peter
    Lehmann, Helmar
    Kieseier, Bernd C.
    NEUROLOGY, 2007, 68 (12) : A251 - A251
  • [3] INHIBITION FOR PROLIFERATION OF HUMAN RETINAL-PIGMENT EPITHELIUM BY INTERFERON-BETA IN-VITRO
    YAMADA, H
    OGATA, N
    MATSUSHIMA, M
    UYAMA, M
    DELMONTE, MA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S99 - S99
  • [4] IN-VITRO IMMUNOMODULATING EFFECTS OF INTERFERON-BETA
    REP, MHG
    HINTZEN, RQ
    POLMAN, CH
    VANLIER, RAW
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 153 - 153
  • [5] Interaction of PEGylated interferon-beta with antibodies to recombinant interferon-beta
    Gilli, Francesca
    De la Torre, Adrianna L.
    Royce, Darlene B.
    Pachner, Andrew R.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 62 : 1 - 6
  • [6] Neutralising antibodies against interferon-beta neutralise natural interferon-beta
    Sominanda, A.
    Menge, T.
    Hemmer, B.
    Hartung, H. P.
    Kieseier, B. C.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S134 - S134
  • [7] INDUCTION OF INTERFERON-ALPHA BY INTERFERON-BETA, BUT NOT OF INTERFERON-BETA BY INTERFERON-ALPHA, IN THE MOUSE
    ASANO, M
    HAYASHI, M
    YOSHIDA, E
    KAWADE, Y
    IWAKURA, Y
    VIROLOGY, 1990, 176 (01) : 30 - 38
  • [8] Interferon-Beta for Glomerulonephritis?
    Wardle, E. Nigel
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2007, 18 (03) : 333 - 336
  • [9] Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines
    Garrison, JI
    Berens, ME
    Shapiro, JR
    Treasurywala, S
    FloydSmith, G
    JOURNAL OF NEURO-ONCOLOGY, 1996, 30 (03) : 213 - 223
  • [10] IN-VITRO AND IN-VIVO INHIBITION OF MITOGEN-DRIVEN T-CELL ACTIVATION BY RECOMBINANT INTERFERON-BETA
    RUDICK, RA
    CARPENTER, CS
    COOKFAIR, DL
    TUOHY, VK
    RANSOHOFF, RM
    NEUROLOGY, 1993, 43 (10) : 2080 - 2087